Solventum Corp (SOLV) stock
SOLVNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 6/3092% above fair value
$88.81+0.19 (+0.21%)
Close on Nov 12, 2026Market cap $15.12BP/E 99.8Yield –
Solventum cash
Cash and short-term investments held at the end of each period.
Solventum's cash was $451.00M at Sep 30, 2026. For fiscal 2025 it was $878.00M, up 15.2% from the year before. The highest annual figure on record is $878.00M in fiscal 2025.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $878.00M | +15.2% |
| FY2024 | Dec 31, 2024 | $762.00M | +292.8% |
| FY2023 | Dec 31, 2023 | $194.00M | +218.0% |
| FY2022 | Dec 31, 2022 | $61.00M | -33.0% |
| FY2021 | Dec 31, 2021 | $91.00M | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $451.00M | -72.5% |
| Q2 FY2026 | Jun 30, 2026 | $403.00M | -18.1% |
| Q1 FY2026 | Mar 31, 2026 | $561.00M | +5.1% |
| Q4 FY2025 | Dec 31, 2025 | $878.00M | +15.2% |
| Q3 FY2025 | Sep 30, 2025 | $1.64B | +112.7% |
| Q2 FY2025 | Jun 30, 2025 | $492.00M | -45.2% |
| Q1 FY2025 | Mar 31, 2025 | $534.00M | -46.4% |
| Q4 FY2024 | Dec 31, 2024 | $762.00M | +292.8% |
| Q3 FY2024 | Sep 30, 2024 | $772.00M | +1738.1% |
| Q2 FY2024 | Jun 30, 2024 | $897.00M | +2200.0% |
| Q1 FY2024 | Mar 31, 2024 | $996.00M | +2216.3% |
| Q4 FY2023 | Dec 31, 2023 | $194.00M | +218.0% |
| Q3 FY2023 | Sep 30, 2023 | $42.00M | -53.8% |
| Q2 FY2023 | Jun 30, 2023 | $39.00M | – |
| Q1 FY2023 | Mar 31, 2023 | $43.00M | – |
| Q4 FY2022 | Dec 31, 2022 | $61.00M | – |
| Q4 FY2021 | Dec 31, 2021 | $91.00M | – |
See a number that looks wrong?